Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...
New research provides a mechanistic map of how genetic mutations disrupt RNA splicing in acute myeloid leukemia.
Panelists discuss how splice modifiers work by enhancing protein production from the SMN2 gene, with risdiplam (Evrysdi) being an oral daily medication and nusinersen (Spinraza) being administered ...
News Medical on MSN
Why Some Retinitis Pigmentosa Cases Went Undiagnosed for Decades
Researchers led by the Institute of Molecular and Clinical Ophthalmology Basel uncovered disease-causing variants in ...
A new research paper featured as the cover of Volume 17, Issue 12 of Aging-US was published on December 22, 2025, titled “A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback